This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

CHESSMEN Board meets in Rome to discuss shortage prevention.

BASG informs about current developments and necessary measures in case of counterfeiting of the medicinal product Ozempic® in German presentation.

On Friday 18.8.2023 a delegation of the Chinese Drug Administration Zhejiang Medical Products Administration visited the AGES Medical Market Surveillance for an exchange and deeper insights into the fields of activity.

10 years after the review of iron-containing drugs for intravenous use associated with allergic reactions, cautions are recalled.

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

New recommendations for the composition of seasonal influenza vaccines for the season 2023/2024 adopted.

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

Dr. Vlasta Zavadova, Director of the Liechtenstein Medicines Agency visits AGES Medical Market Surveillance for further development of the State Treaty.

Prof. Dr. Karl Broich, President of the BfArM (Federal Institute for Drugs and Medical Devices) visits the AGES Medical Market Surveillance.